La primera señal apareció cuando Deepanwita Dasgupta tenía 5 años y empezó a tropezar más a menudo mientras jugaba en su casa en Bangalore, en el sur de India. La niña siempre estaba haciendo algo; por eso sus padres pensaron que los golpes y moretones extra eran simplemente parte de una infancia activa. Quizás, pensaron,…
As the pool of approved therapies continues to (hopefully) expand, the clinical and diagnostic testing communities need to do a better job at ensuring the right patients move through this journey more quickly – and accurately – to improve their health and prognosis. The post Why Blood is Best: Transforming the Diagnostic Journey for Alzheimer’s…
Expanding the diversity of our mental health workforce is crucial, but it’s a long-term goal that won’t address the immediate needs we’re facing today. We need solutions now to bridge the gap between demand and access. The post Mental Healthcare in Underserved Populations is in Crisis and It’s Not Just a Provider Resource Problem appeared…
The clinical decision support market is evolving quickly. With heavy investor backing and competing strategies around specialization, data depth and distribution, the coming years will determine which companies emerge as lasting leaders at the point of care. The post Inside the Clinical Decision Support Market: The Race to Make AI Work at the Point of…
From a marketing perspective, there are three significant trends to watch in 2025 — strategic brand partnerships, AI-driven healthcare information delivery, and the fundamental shift in social media engagement paradigms. The post Healthcare Marketing: Key Trends Shaping 2025 appeared first on MedCity News.
There were only five hospital M&A transactions during the first quarter of 2025 — a slump caused the Trump administration’s flurry of new policies and the resulting economic uncertainty. Hospitals are putting off mergers for the time being, though some are forming joint ventures as a defense mechanism against financial uncertainty. Many are instead shedding…
Neurovalens’ Modius Spero has become the first FDA-approved neuromodulation device for treating PTSD symptoms. Veterans are set to gain access through the VA this summer. The post FDA Clears First Neurostimulation Device for PTSD appeared first on MedCity News.
Startup execs envision a standard set of practices combined with federated networks of organizations to do quality assurance of AI at scale
KalVista Pharmaceuticals’ Ekterly is now FDA approved for treating acute swelling attacks from hereditary angioedema. The KalVista tablet provides an alternative to injectable or infused HAE medications from companies such as Takeda Pharmaceutical and CSL Behring. The post KalVista Drug Gets FDA Approval for Treating Acute Swelling Attacks From Rare Disease appeared first on MedCity…
Harrowing scenes are unfolding at health facilities at the epicenter of an Ebola outbreak in the Democratic Republic of Congo. A 25-year-old midwife and a doctor in his early 30s are sick with Ebola symptoms, including fevers and severe joint pain, said their colleague Elisabeth Furaha, the medical director at SOFEPADI’s Karibuni Wa Mama Medical…